Skip navigation
Home
Menu
Menu
Study
Student life
Research and innovation
Global
About us
Staff
Students
Search the site
Centre of Excellence for Long-acting Therapeutics
Menu
About us
LONGEVITY Project
Nanotherapeutics Hub
Teoreler
PKRxiv
LAPaL
Blog
Our News
Events
Contact us
News
ViiV Healthcare announces CHMP positive opinion for Vocabria + Rekambys, the first and only complete long-acting HIV treatment, for adolescents in Europe
20 December 2024
Johnson & Johnson denied extension of patent on TB drug, to benefit patients
20 December 2024
Neuraxpharm and Pharmathen enter into strategic co-development agreement to develop long-acting injectable therapies
13 December 2024
Global leaders in the HIV response call for access to long-acting medicines
13 December 2024
Sirius Therapeutics to Present Data from Its Phase 1 Clinical Trial of Factor XI siRNA, a Long-Acting Next-Generation Anticoagulant for Thromboembolic Disorders
06 December 2024
Unitaid invests US$22m to accelerate access to lenacapavir, a groundbreaking new HIV prevention drug
06 December 2024
Rapid initiation with Sublocade improves retention for opioid use disorder treatment
29 November 2024
MSF to roll out injectable HIV prevention drug in southern Africa
29 November 2024
Long-Acting Drugs Market Revolutionizing Therapeutics with Sustained-Release Innovations and Emerging Opportunities
29 November 2024
Gilead Announces New England Journal of Medicine Publication of PURPOSE 2 Results
29 November 2024
News
ViiV Healthcare announces CHMP positive opinion for Vocabria + Rekambys, the first and only complete long-acting HIV treatment, for adolescents in Europe
20 December 2024
Johnson & Johnson denied extension of patent on TB drug, to benefit patients
20 December 2024
Neuraxpharm and Pharmathen enter into strategic co-development agreement to develop long-acting injectable therapies
13 December 2024
Global leaders in the HIV response call for access to long-acting medicines
13 December 2024
Sirius Therapeutics to Present Data from Its Phase 1 Clinical Trial of Factor XI siRNA, a Long-Acting Next-Generation Anticoagulant for Thromboembolic Disorders
06 December 2024
Unitaid invests US$22m to accelerate access to lenacapavir, a groundbreaking new HIV prevention drug
06 December 2024
Rapid initiation with Sublocade improves retention for opioid use disorder treatment
29 November 2024
Older Stories
